SANUWAVE Health Announces Updated Guidance for Quarter Ended June 30, 2026

What Happened
SANUWAVE Health, Inc. filed a Current Report on Form 8-K on June 16, 2026 (Item 7.01 - Regulation FD Disclosure) to announce updated guidance for the quarter ended June 30, 2026. The company issued a press release dated June 16, 2026 containing the guidance; that press release is attached to the 8-K as Exhibit 99.1. The report was signed by CEO Morgan C. Frank.

Key Details

• Filing date: June 16, 2026 (Form 8-K, Item 7.01 - Regulation FD Disclosure).
• Press release dated June 16, 2026 announcing updated guidance for the quarter ended June 30, 2026 (Exhibit 99.1).
• The Form 8-K does not include detailed financial statements or line-item quarterly results in the filing itself.
• Report signed by Chief Executive Officer Morgan C. Frank.

Why It Matters
Updated guidance directly affects investor expectations for quarterly results (revenue/earnings) and can influence the stock price once specifics are reviewed. Because this disclosure was made under Regulation FD, the information was shared publicly via a press release; investors should read the attached press release (Exhibit 99.1) and any subsequent filings for the exact numerical guidance and any impact on quarterly earnings or revenue projections.